Related references
Note: Only part of the references are listed.Soluble TL1A is sufficient for activation of death receptor 3
Sebastian Bittner et al.
FEBS JOURNAL (2016)
Principles of antibody-mediated TNF receptor activation
H. Wajant
CELL DEATH AND DIFFERENTIATION (2015)
DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers
Sachin Gupta et al.
JOURNAL OF VIROLOGY (2015)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity
Saravana Kanagavelu et al.
PLOS ONE (2014)
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
J. Trebing et al.
CELL DEATH & DISEASE (2014)
Engineering death receptor ligands for cancer therapy
Harald Wajant et al.
CANCER LETTERS (2013)
Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction
Jawahar Sudhamsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Bharat B. Aggarwal et al.
BLOOD (2012)
Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)
Andrea Fick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts
Isabell Lang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
Christopher A. Nelson et al.
STRUCTURE (2012)
Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine
Saravana K. Kanagavelu et al.
VACCINE (2012)
Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
Wan-Wan Lin et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Expression and Purification of a Natural N-Terminal Pre-ligand Assembly Domain of Tumor Necrosis Factor Receptor 1 (TNFR1 PLAD) and Preliminary Activity Determination
Jin Cao et al.
PROTEIN JOURNAL (2011)
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Chenyang Zhan et al.
STRUCTURE (2011)
TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
H. Rauert et al.
CELL DEATH & DISEASE (2011)
Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy
Tomohiro Morishige et al.
BIOMATERIALS (2010)
Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
Hilka Rauert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
Biological Activity of Ectodysplasin A Is Conditioned by Its Collagen and Heparan Sulfate Proteoglycan-binding Domains
Lee Kim Swee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
Agnes Wyzgol et al.
JOURNAL OF IMMUNOLOGY (2009)
Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells
Dmitri V. Rozanov et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization
Nicole Mueller et al.
FEBS JOURNAL (2008)
Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activity
Anja Krippner-Heidenreich et al.
JOURNAL OF IMMUNOLOGY (2008)
Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily
Kausik Chattopadhyay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states
Zhaocai Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen et al.
BLOOD (2008)
A novel method for determination of the affinity of protein: Protein interactions in homogeneous assays
Philip Newton et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function
Kausik Chattopadhyay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L
D. Berg et al.
CELL DEATH AND DIFFERENTIATION (2007)
Investigating the interaction between osteoprotegerin and receptor activator of NF-κB or tumor necrosis factor-related apoptosis-inducing ligand
Srdjan Vitovski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Stoichiometry of LTβR binding to LIGHT
John Eldredge et al.
BIOCHEMISTRY (2006)
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules
Sharron A. N. Brown et al.
BIOCHEMICAL JOURNAL (2006)
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines
GW Stone et al.
JOURNAL OF VIROLOGY (2006)
Production of recombinant human trimeric CD137L (4-1BBL) -: Cross-linking is essential to its T cell co-stimulation activity
C Rabu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-κB ligand
LA Schneeweis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation
J Hendriks et al.
CELL DEATH AND DIFFERENTIATION (2005)
Identification of proteoglycans as the APRIL-specific binding partners
K Ingold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA
ES Day et al.
BIOCHEMISTRY (2005)
Engineering an APRIL-specific B cell maturation antigen
DR Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex
N Holler et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
SR Wiley et al.
IMMUNITY (2001)
Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative
H Wajant et al.
ONCOGENE (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-κB and ELF-1
P Kanakaraj et al.
CYTOKINE (2001)
Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS
YM Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Expression, purification, and characterization of the human receptor activator of NF-κB ligand (RANKL) extracellular domain
D Willard et al.
PROTEIN EXPRESSION AND PURIFICATION (2000)
Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor
A Truneh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL
SG Hymowitz et al.
BIOCHEMISTRY (2000)
Share Paper
